Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Cho, H. Kim, Y. Jeong, J. Lee, Y. Hwang (Jinju, Republic Of Korea). Comparison of serum osteopontin levels in patients with exacerbations and stable chronic obstructive pulmonary disease. Eur Respir J 2012; 40: Suppl. 56, 2225

Member's Comments

No comment yet.

Related content which might interest you: Serum angiopoietin-2 levels in stable and exacerbated chronic obstructive pulmonary disease Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Serum magnesium levels of patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 107s Year: 2003 Serum leptin levels in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 259s Year: 2002 Serum interferon-gamma levels in chronic obstructive pulmonary disease and asthma patients: correlation with respiratory parameters Source: Eur Respir J 2001; 18: Suppl. 33, 75s Year: 2001 Serum amyloid A in patients with stable chronic obstructive pulmonary disease Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018 High interleukin-33 is associated with acute exacerbation in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Periostin levels in chronic obstructive pulmonary disease (COPD) Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Changes in antioxidant enzyme levels in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury Year: 2009 A study of the level of interleukin-32 in induced sputum and plasma of patients with chronic obstructive pulmonary disease and asthma Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 Relationship between serum levels of testosterone and the severity of chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Investigations of COPD Year: 2020 The levels of serum malonyldialhyde and paraoxonase in chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004 Comparison of blood eosinophils and plasma periostin in stable and non-stable chronic obstructive pulmonary disease: How we can improve the management of our patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Plasma fibrinogen in patients with chronic obstructive pulmonary disease (COPD) with or without secondary erythrocytosis Source: Eur Respir J 2005; 26: Suppl. 49, 586s Year: 2005 Simvastatin does not reduce levels of inflammatory blood markers in patients with stable chronic obstructive pulmonary disease Source: Annual Congress 2008 - COPD Year: 2008 Relationship between circulating thrombomodulin levels and latent progression of atherosclerosis in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Increased urinary l-histidine in patients with asthma–chronic obstructive pulmonary disease overlap Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 IL-8 in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 364s Year: 2001 Association between serum YKL-40 and chronic obstructive pulmonary disease Source: International Congress 2017 – COPD biomarkers Year: 2017 Serum lysophosphatidic acid levels and exacerbation frequency in chronic obstructive pulmonary disease (COPD) Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung Year: 2020 Variability in expression of aquoporine 1 in chronic obstructive pulmonary disease and interstitial lung disease patients Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009